NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies
NIST and collaborators have developed a new line of mAb-producing living cells that can help manufacturers better understand how their ...
Tag: Therapeutic Antibodies
Targeting Poxviruses with Messenger RNA Technology
Scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) working with industry partners are among the first ...
Antibody Shows Promise for Developing Hantavirus Treatment
An international research team discovered the first human antibody to effectively neutralize two types of hantaviruses in animal models, according ...
U.S. Purchases 600,000 Courses of Eli Lilly Monoclonal Antibody That Works Against Omicron
The U.S. Department of Health and Human Services (HHS) announced on Feb 10. it will acquire 600,000 treatment courses of ...
Biodefense and Countering Disease with Neutralizing Antibodies
After screening a large, diverse library of synthetic nanobodies, Sandia researchers identified and evaluated several potent nanobodies that can protect ...
By Targeting Key Part of Spike Protein, This Antibody Protects Against Broad Range of COVID Variants
Researchers working in a BSL-3 lab at the Washington University School of Medicine in St. Louis have identified an antibody ...
Coronavirus Immunotherapeutic Consortium Identifies Surfaces of Spike Most Resistant to Antibody Escape
Hundreds of antibodies contributed by over 50 different organizations around the world were classified and mapped. This study shows exactly ...
HHS Awards $2.9B to Regeneron for COVID-19 Therapy
The U.S. Department of Health and Human Services (HHS) and the Department of Defense (DOD) will purchase 1.4 million additional ...
WRAIR, Duke Scientists Find Evidence of Monoclonal Antibody Activity Against Malaria
Scientists at Walter Reed Army Institute of Research, in a collaboration with Duke University, have confirmed that monoclonal antibodies can ...
Naval Medical Center San Diego Administers Hospital’s First mAb Treatment to COVID-19 Patient
Naval Medical Center San Diego (NMCSD) administered the hospital’s first monoclonal antibody (mAb) treatment to a COVID-19-positive patient Jan. 26. ...
Regeneron Halts Trial for Antibody Cocktail in Sickest COVID-19 Patients
Based on the recommendation of the independent data monitoring committee (IDMC), Regeneron Pharmaceuticals has stopped enrolling patients receiving advanced COVID-19 care ...
FDA Approves First Ebola Therapeutic
The U.S. Food and Drug Administration this week approved Inmazeb, previously called REGN-EB3, a mixture of three monoclonal antibodies made ...
DoD Researchers Collaborate on Universal Antibody Test for COVID-19
Researchers from the U.S. Army Futures Command, in collaboration with Houston Methodist, Pennsylvania State University, and UT Austin, tested alternative ...
Eli Lilly Says Antibody Combo Effective Against COVID, Asks for EUA
Eli Lilly and Company today announced additional details on its SARS-CoV-2 neutralizing antibody programs – including interim data on combination therapy ...
Urgent Phase I/II Clinical Trial Funding to Repurpose Existing Therapeutics to Treat COVID-19
The National Institutes of Health has issued an urgent funding opportunity announcement to invite applications to repurpose existing therapeutic agents ...
Antibodies from SARS Patient Blocks SARS and SARS-CoV-2 in Lab
The neutralizing antibody, called S309, is on an accelerated path toward clinical trials An antibody first identified in a blood ...
X-Ray Experiments Zero in on COVID-19 Antibodies
Scientists reveal potential coronavirus therapy using structural biology and the Advanced Light Source As scientists across the globe race to ...
NIAID to Hold Closed Meeting on Biodefense Medical Countermeasure Funding
A Special Emphasis Panel of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of ...
Alexion to Initiate Phase 3 Study of Rare Blood-Disorder Drug in Severe COVID-19 Patients
Alexion Pharmaceuticals Inc. announced today it would start a late-stage study of its rare blood-disorder drug, Ultomiris, in COVID-19 patients ...
BARDA Facilitates Development of Immunotherapies for COVID-19 Patients
The U.S. Department of Health and Human Services (HHS) will collaborate with multiple non-government organizations on the development of convalescent ...
